Passionflower for Anxiety

Verdict: Promising but too thin to confirm

A handful of small trials hint that passionflower may ease anxiety, but the evidence is too limited and short-term to confirm it works, and it carries real sedative drug-interaction risks. It should not replace proven treatments.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade is Weak (C) because the human evidence is small and sparse rather than negative. A Cochrane systematic review (PMID 17253512), pooling just two RCTs in 198 people, concluded the data were too limited to draw firm conclusions, even though one trial suggested an effect comparable to benzodiazepines. The pilot generalized-anxiety RCT it drew on (PMID 11679026, n=36) found passionflower no different from oxazepam over four weeks, but with only 36 patients this cannot establish efficacy on its own.

Two short preoperative trials add directional support: passionflower lowered situational anxiety versus placebo before surgery (PMID 18499602, n=60) and performed similarly to midazolam before dental extraction (PMID 27918731, n=40). These are single-dose, non-inferiority designs in narrow settings, so they say little about treating an ongoing anxiety disorder, and funding was undisclosed for both.

Authorities echo the caution. The US FDA lists passionflower only as a flavoring food substance with no disease claim, the NIH Office of Dietary Supplements calls the evidence limited and inconsistent, and Europe's EMA recognizes only a traditional use for mild stress. Passionflower can also add to the sedation of benzodiazepines, alcohol, and anesthesia, so it is best avoided around surgery and in pregnancy, and should not replace first-line care such as therapy or SSRIs.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.59
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
65%
Broadly consistent
Evidence level
E1
Cochrane high-quality SR/MA

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.51
L2 PubMedPrimary literature
0.60
L3 MechanismPlausibility
0.75
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.594
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — | B→C 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Passiflora for anxiety disorder (Cochrane Database Systematic Review)
PMID: 17253512 2007 系統性回顧 n = 198
Finding: Only 2 RCTs (198 participants) identified; evidence too sparse to draw conclusions, though one trial suggested efficacy comparable to benzodiazepines (not statistically significant).
Academic
View on PubMed
Passionflower in the treatment of generalized anxiety: pilot double-blind RCT with oxazepam (Akhondzadeh)
PMID: 11679026 2001 RCT (double-blind) n = 36
Finding: No significant difference between passionflower and oxazepam at trial end; oxazepam acted faster but caused more job-performance impairment.
Academic
View on PubMed
Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients (Movafegh)
PMID: 18499602 2008 RCT (double-blind) n = 60
Finding: NRS anxiety scores significantly lower in passiflora group vs placebo (P < 0.001), without psychomotor sedation.
View on PubMed
Effects of Passiflora incarnata and midazolam for control of anxiety in patients undergoing dental extraction (Dantas)
PMID: 27918731 2017 RCT (double-blind) n = 40
Finding: Passiflora incarnata showed an anxiolytic effect similar to midazolam; >70% felt calm/slightly anxious under both, no significant differences in physiological parameters.
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Neutral
PASSION FLOWER (PASSIFLORA INCARNATA L.) source↗
L4b EU EFSA
Neutral
L4d TW TFDA / 衛福部
Cautious
未經確認其食用安全性前,不得供為食品原料使用。 source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-anxiety-INT-passionflower-001 繁體中文版 →